|
RABL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7009005315316E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.23730051046789E-10 |
| Normal-vs-Stage2 |
1.860410E-01 |
| Normal-vs-Stage3 |
8.248500E-04 |
| Normal-vs-Stage4 |
2.044500E-03 |
| Stage1-vs-Stage2 |
1.637040E-01 |
| Stage1-vs-Stage3 |
5.484400E-01 |
| Stage1-vs-Stage4 |
2.369400E-01 |
| Stage2-vs-Stage3 |
1.897980E-01 |
| Stage2-vs-Stage4 |
1.083800E-01 |
| Stage3-vs-Stage4 |
5.453400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.93010002109185E-09 |
| Normal-vs-AfricanAmerican |
3.279799998257E-08 |
| Normal-vs-Asian |
5.14439999488303E-08 |
| Caucasian-vs-AfricanAmerican |
3.574200E-01 |
| Caucasian-vs-Asian |
1.632430E-01 |
| AfricanAmerican-vs-Asian |
1.459560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51709764143015E-11 |
| Normal-vs-Female |
1.603350E-03 |
| Male-vs-Female |
7.602300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.33479999947706E-07 |
| Normal-vs-Extreme_Weight |
1.2365000023884E-08 |
| Normal-vs-Obese |
7.86959999999892E-05 |
| Normal-vs-Extreme_Obese |
5.294400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.520400E-01 |
| Normal_Weight-vs-Obese |
1.649020E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.801400E-01 |
| Extreme_Weight-vs-Obese |
1.574560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.435600E-01 |
| Obese-vs-Extreme_Obese |
7.950000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.55500123467345E-11 |
| Normal-vs-Age(41-60Yrs) |
3.61540000004545E-06 |
| Normal-vs-Age(61-80Yrs) |
7.81580000719373E-09 |
| Normal-vs-Age(81-100Yrs) |
2.769700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.698220E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.488400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.096600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.879770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.664400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.897400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68550000001488E-06 |
| Normal-VS-Type2 PRCC |
2.42569999642228E-08 |
| Normal-VS-KIRP CIMP |
3.495200E-03 |
| Normal-VS-Unclassified PRCC |
4.142200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.118000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.764400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.852000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.330000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.282200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.779200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.80617759532242E-12 |
| Normal-vs-N1 |
1.833860E-04 |
| Normal-vs-N2 |
2.754800E-01 |
| N0-vs-N1 |
5.387400E-01 |
| N0-vs-N2 |
6.851800E-01 |
| N1-vs-N2 |
9.416800E-01 |
|
|
